Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Allergy & Immunology
•
GI Eosinophilic Disorders
Do you use asthma or EoE dosing if initiating dupilumab in a patient who meets criteria for treatment for both disorders?
Answer from: at Community Practice
I would do the higher dose (EoE) if starting it for both.
Sign in or Register to read more
23638
Related Questions
Is there a role for use of dupilumab for hypereosinophilic GI disorders distal to the esophagus?
Can a biopsy finding of eosinophilia in the gut (esophagus, stomach, duodenum) be reactive in the setting of Crohn's disease or due to anti-TNF blockade?
If you have a patient with EoE on Dupixent 300 mg weekly, and they have severe tree nut allergies, would it be safe to add Xolair for severe food allergy?
Is there a role for anti-IL5 therapy in the treatment of EoE?
What patients with food allergies do you screen for EoE?
How often do you find a food allergy on a skin test in an EoE patient that when avoided will result in significant resolution of EoE?
How exhaustive (especially considering cost) should an immunological workup be for patients with extensive, recurrent, or deep seated Staph aureus infections without obvious immunocompromise (e.g. cancer, diabetes, steroids) or recurrent breaks in skin integrity?
Are there any immunosuppressive agents that have been shown to have utility in concurrent idiopathic anaphylaxis?
Do you perform patch testing with a history of SCAR with the goal of performing a drug challenge?
Do you recommend patients try antihistamines such as oral ketotifen that are not approved in the US but are approved in the EU for MCAS if currently available formulations have not been effective?